By quantifying the total amount of VEGF produced during a 24-hour span, the model simulates and compares dose-responses of two therapeutic approaches, overexpressing let-7 and antagonizing miR-15a, which we proposed to enhance VEGF synthesis in PAD (Fig 7E and 7F). Here, VEGFA is linked to peripheral arterial disease.